A Prospective Patient Registry of Patients Exposed to Bedaquiline
Status:
Completed
Trial end date:
2018-11-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the medical indication and utilization of expert
medical consultation among participants treated with bedaquiline (BDQ), BDQ susceptibility
based on minimum inhibitory concentrations (MICs) reported for baseline and subsequent
isolates, BDQ drug utilization data to include dose, duration, past treatment history, past
medical history, concomitant medications, and health care site of treatment, drug
distribution mechanisms used in the administration of BDQ, patient outcomes (clinical and
microbiologic) and adverse events among BDQ-treated participants, including deaths.